Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
Alibaba Bets on AI Agents to Unify Its Vast Digital Ecosystem
Palantir's Maven AI Earns Pentagon "Program of Record" Status, Reshaping Military AI Strategy
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Nvidia Develops Groq AI Chips for Chinese Market Amid Export Shift
AMD CEO Lisa Su Heads to Samsung's South Korea Chip Facility Amid AI Expansion Talks
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
NVIDIA's Feynman AI Chip May Face Redesign Amid TSMC Capacity Crunch
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Malaysia Semiconductor Industry Eyes Helium Supply Risks Amid Middle East Conflict
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas
Jeff Bezos Eyes $100 Billion Fund to Transform Manufacturing With AI 



